WEGO
WEGO
Shandong Weigao Group Medical Polymer Products Co. and its subsidiaries are principally engaged in the research and development
Shandong Weigao Group Medical Polymer Products Co. and its subsidiaries are principally engaged in the research and development, manufacture and sale of disposable medical devices. We provide different kinds of products, including: i) consumables (infusion sets, syringes, medical needle products, blood bags, pre-filled syringes, blood collection products and other consumables used); ii) bone materials and iii) blood purification consumables and equipment. The Company is the industrialization base of the achievements of the National High Technology Research and Development (863) Program of China, a national high-tech enterprise and a national enterprise technology center. The main production base of the Group is located in Weihai City, Shandong Province, the PRC.
- All
- News
- Analysis
- Research
Briefing Sep 09, 2022 04:12 PM
· Healthcare
Trulive Nets Hundreds of Mns of CNY in pre-Series B Financing Round
Briefing Sep 05, 2022 04:50 PM
· Healthcare
LinkZill Nets Tens of Millions of CNY in pre-Series A+
In-depth
Healthcare
2022 Informatization of China's Rehabilitation Industry
The rehabilitation industry caught the attention of the Chinese government again in 2021, and the industry entered a phase of accelerated development. The rehabilitation industry will first supplement medical resources and continue to explore a rehabilitation model that suits China's actual conditions. Under this context, EqualOcean Intelligence, together with Neusoft Group, released the 2022 Research Report On the Informatization of China's Rehabilitation Industry.
Sep 01, 2022 10:11 AM
Briefing Aug 01, 2022 03:11 PM
· Healthcare
Biomedical Lab Supplies Producer Acumen Bags 100 Mn of CNY in Series A Round
Briefing Jun 24, 2022 11:15 AM
· Healthcare
F-star to be acquired by China biopharmaceutical with USD 161million
Aug 29, 2022 05:45 PM
Apr 22, 2021 03:11 PM
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Briefing Jun 24, 2022 11:07 AM
· Healthcare
"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange
Briefing Jun 24, 2022 10:46 AM
· Healthcare
East China medicine "liraglutide" goes to sea
Briefing Jun 23, 2022 06:25 PM
· Healthcare
Nearly half of the equity of two subsidiaries of Tongrentang was transferred to Tongrentang medical care
Healthcare
MIGS Developer Health Guard Biomed Nets CNY 100 Mn in Series A Round
This financing round is mainly used to promote the multicenter clinical trials of the company's micro-invasive glaucoma products and accelerate the R&D, clinical application and production of other innovative ophthalmic products.
Sep 19, 2022 06:06 PM
Briefing Jun 23, 2022 06:24 PM
· Healthcare
Baiyunshan: suspension of the spin off of Guangzhou Pharmaceutical for overseas listing
Briefing Jun 23, 2022 10:36 AM
· Healthcare
Germany Merck "cetuximab" new indications for head and neck squamous cell carcinoma approved in China
Briefing Jun 23, 2022 10:27 AM
· Healthcare
Yanye new crown drug 3CL protein inhibitor has been suspended approval
Briefing Jun 23, 2022 10:24 AM
· Healthcare
Sanofi Greater China will be headed by Shi Wang, and Henting he will become the global head of the digital business unit
Briefing Jun 23, 2022 10:22 AM
· Healthcare
Acadia Alzheimer's drug SNDA application rejected by FDA advisory committee
Briefing Jul 20, 2021 03:33 PM
· Technology
Ruiyuan Zhao Feng position announced in the second quarter, Xiaomi group is still the largest position stocks
See more
Related Companies
